Compounds > flumazenil

flumazenil and nalbuphine

flumazenil has been researched along with nalbuphine in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (37.50)	18.2507
2000's	4 (50.00)	29.6817
2010's	1 (12.50)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Topliss, JG; Yoshida, F	1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Lombardo, F; Obach, RS; Waters, NJ	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Fassoulaki, A; Vassiliou, M	1
Achtari, R; Baasch, K; Schaer, H	1

Reviews

1 review(s) available for flumazenil and nalbuphine

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Trials

1 trial(s) available for flumazenil and nalbuphine

Article	Year
[Antagonism of flunitrazepam and fentanyl by flumazenil, naloxone or nalbuphine]. Der Anaesthesist, 1990, Volume: 39, Issue:1 Topics: Adult; Double-Blind Method; Fentanyl; Flumazenil; Flunitrazepam; Humans; Middle Aged; Morphinans; Nalbuphine; Naloxone; Randomized Controlled Trials as Topic; Respiratory Insufficiency	1990

Other Studies

6 other study(ies) available for flumazenil and nalbuphine

Article	Year
QSAR model for drug human oral bioavailability. Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13 Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
IFDAS Research Council Report 1988-91: Midazolam. Anesthesia & pain control in dentistry, 1992,Summer, Volume: 1, Issue:3 Topics: Anesthesia, Dental; Conscious Sedation; Drug Combinations; Flumazenil; Humans; Midazolam; Nalbuphine; Pentazocine; Societies, Dental	1992
[Flumazenil and respiratory depression induced by midazolam-fentanyl or midazolam-nalbuphine combinations]. Cahiers d'anesthesiologie, 1991, Volume: 39, Issue:1 Topics: Adult; Anesthesia, Intravenous; Depression, Chemical; Female; Fentanyl; Flumazenil; Humans; Mastectomy; Midazolam; Nalbuphine; Respiration	1991